Merck’s $1.35 Billion Acquisition of Imago BioSciences, Inc.

Goodwin Procter advised Centerview Partners on the deal, Latham & Watkins represented Imago BioSciences, Gibson Dunn & Crutcher advised Merck.Merck (NYSE: MRK) and Imago BioSciences, Inc. (Nasdaq:…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here